USA –
BOSTON, MA, Dyad Medical has closed its oversubscribed seed financing round.
Dyad Medical, a groundbreaking medical image analysis platform delivering cloud-based artificial intelligence (AI)-based analysis, announced after just 90 days, the closing of its oversubscribed Series Seed funding round led by The Unofficial Syndicate, with participation by Social Starts L.P., and local angel investors. Along with grants from the NIH, this brings Dyad's total funding to more than $3.5MM.
Dyad Medical develops clinical applications using cloud-based artificial intelligence aimed at enabling doctors to more efficiently interpret medical image content from anywhere in the world. It is powered by the expertise of a global community of clinicians who train the model, effectively offering practitioners "thousands of second opinions" in real-time. Within the digital diagnostics arena, Dyad Medical's core focus is on cardiac imaging because more people die as a result of cardiovascular disease than all types of cancer, diabetes, and accidents combined. www.dyadmed.com
Dyad Medical
Boston, MA
